Kits Eyecare (TSE:KITS) Given a C$23.00 Price Target at Desjardins

Kits Eyecare (TSE:KITS) received a C$23.00 target price from equities research analysts at Desjardins in a research report issued to clients and investors on Monday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Desjardins’ target price suggests a potential upside of 36.58% from the company’s previous close.

KITS has been the subject of a number of other research reports. Stifel Nicolaus lowered their price target on shares of Kits Eyecare from C$24.00 to C$21.00 and set a “buy” rating for the company in a report on Thursday, May 7th. ATB Cormark Capital Markets reduced their price objective on Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating on the stock in a research note on Thursday, May 7th. Finally, Canaccord Genuity Group decreased their price objective on Kits Eyecare from C$23.00 to C$22.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Four investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of C$20.69.

Kits Eyecare Trading Up 1.5%

KITS traded up C$0.25 during trading hours on Monday, hitting C$16.84. The company’s stock had a trading volume of 54,364 shares, compared to its average volume of 114,623. The firm has a market cap of C$572.66 million, a PE ratio of 105.25 and a beta of 0.06. The firm has a 50-day moving average of C$14.05. Kits Eyecare has a 12 month low of C$10.61 and a 12 month high of C$22.56.

Kits Eyecare (TSE:KITS) last released its quarterly earnings data on Wednesday, August 5th. The company reported C$0.04 EPS for the quarter. The business had revenue of C$58.43 million for the quarter.

Insider Buying and Selling

In related news, insider Joseph Thompson sold 75,000 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of C$13.65, for a total value of C$1,023,750.00. Following the sale, the insider directly owned 960,114 shares of the company’s stock, valued at C$13,105,556.10. This represents a 7.25% decrease in their position.

Kits Eyecare Company Profile

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.